Healthcare & Life Sciences

A new report reveals a grim reality: the typical American worker has under $1,000 for retirement. Is the system, not the saver, fundamentally broken?

Thousands of survivors face renewed hardship as LA County's landmark $4B sex abuse settlement is frozen amid widespread fraud investigations involving law firms.

A new partnership combines automated governance with organizational design, promising to help finance and healthcare innovate faster without breaking the rules.

The 2026 Special Olympics USA Games in Minnesota needs 10,000 volunteers. Discover the roles available and why many say the experience is life-changing.

M Health Fairview adopts Nabla's AI to combat doctor burnout, aiming to free clinicians from screens and bring the focus back to patient care.

Over 92,000 students are designing waste-free cities for the Future City Finals, a competition achieving rare gender parity in the STEM field.

Pluristyx and Solesis launch a 'three-in-one' kit with nearly 100% efficiency in iPSC transfection, tackling a major bottleneck in organoid research.

Two industry titans are tackling a major pain point for millions, aiming to make eye makeup safe and comfortable for all contact lens wearers.

Claros Mortgage Trust will report 2025 results on Feb. 18. Investors seek clarity on its strategy for navigating distress in commercial real estate.

Shareholders to vote on a US$3.65 per share all-cash deal, a significant premium that will take the growing respiratory care provider private.

With its lead drug MOLBREEVI under FDA review, Savara's upcoming investor talks are a critical test of its path from clinical trials to market.

A new partnership between Alpha Fit Club and Jersey Sports Group aims to scale a community fitness event with a 'uniquely Jersey' identity and a new digital future.

With backing from the D. E. Shaw group, Threadlock Precision's acquisition of Kremin signals a major consolidation in aerospace and defense manufacturing.

Henkel's blockbuster acquisition of Stahl Group reshapes the specialty chemicals market, triggering a profitable, mandatory exit for minority shareholder Clariant.

With a $60M Series A, Chamber Cardio is using AI and risk-sharing to move cardiology to a value-based model, aiming to fix America's costliest disease.

Cincinnati's Timber Bay Partners oversubscribes its fund, proving investor appetite for specialized strategies in the booming GP-led secondary market.

A nationwide study, with NFL legend Steve Gleason as Participant #1, seeks to uncover why high-performance groups face a disproportionate risk of ALS.

A new framework published in a Nature journal measures AI safety, not just accuracy. A specialized model has already outperformed systems from Google and OpenAI.

Louis Hernandez Jr.'s Foundation sets the stage for its 'Spotlight on Giving' gala, uniting corporate leaders to fund a brighter future for NYC students.

The digital health giant now offers a 50+ cancer blood test, promising early detection. But experts caution on its limits and lack of FDA approval.